ID   CDK9_HUMAN              Reviewed;         372 AA.
AC   P50750; Q5JU24; Q5JU25; Q5U006; Q96TF1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2005, sequence version 3.
DT   05-OCT-2010, entry version 123.
DE   RecName: Full=Cell division protein kinase 9;
DE            EC=2.7.11.22;
DE            EC=2.7.11.23;
DE   AltName: Full=C-2K;
DE   AltName: Full=Cell division cycle 2-like protein kinase 4;
DE   AltName: Full=Cyclin-dependent kinase 9;
DE   AltName: Full=Serine/threonine-protein kinase PITALRE;
GN   Name=CDK9; Synonyms=CDC2L4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=94224836; PubMed=8170997; DOI=10.1073/pnas.91.9.3834;
RA   Grana X., de Luca A., Sang N., Fu Y., Claudio P.P., Rosenblatt J.,
RA   Morgan D.O., Giordano A.;
RT   "PITALRE, a nuclear CDC2-related protein kinase that phosphorylates
RT   the retinoblastoma protein in vitro.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:3834-3838(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-231.
RX   MEDLINE=95209665; PubMed=7695608; DOI=10.1006/bbrc.1995.1375;
RA   Best J.L., Presky D.H., Swerlick R.A., Burns D.K., Chu W.;
RT   "Cloning of a full-length cDNA sequence encoding a cdc2-related
RT   protein kinase from human endothelial cells.";
RL   Biochem. Biophys. Res. Commun. 208:562-568(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-231.
RX   MEDLINE=20363726; PubMed=10903437; DOI=10.1016/S0378-1119(00)00215-8;
RA   Liu H., Rice A.P.;
RT   "Genomic organization and characterization of promoter function of the
RT   human CDK9 gene.";
RL   Gene 252:51-59(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION.
RX   PubMed=9857195; DOI=10.1093/emboj/17.24.7395;
RA   Wada T., Takagi T., Yamaguchi Y., Watanabe D., Handa H.;
RT   "Evidence that P-TEFb alleviates the negative effect of DSIF on RNA
RT   polymerase II-dependent transcription in vitro.";
RL   EMBO J. 17:7395-7403(1998).
RN   [9]
RP   FUNCTION, AND IDENTIFICATION IN A COMPLEX WITH HTATSF1; CCNT1; RNA POL
RP   II; SUPT5H AND NCL.
RX   PubMed=10393184; DOI=10.1093/emboj/18.13.3688;
RA   Parada C.A., Roeder R.G.;
RT   "A novel RNA polymerase II-containing complex potentiates Tat-enhanced
RT   HIV-1 transcription.";
RL   EMBO J. 18:3688-3701(1999).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH CCNK.
RX   MEDLINE=20044695; PubMed=10574912; DOI=10.1074/jbc.274.49.34527;
RA   Fu T.J., Peng J., Lee G., Price D.H., Flores O.;
RT   "Cyclin K functions as a CDK9 regulatory subunit and participates in
RT   RNA polymerase II transcription.";
RL   J. Biol. Chem. 274:34527-34530(1999).
RN   [11]
RP   FUNCTION.
RX   MEDLINE=20369654; PubMed=10912001; DOI=10.1016/S1097-2765(00)80272-5;
RA   Wada T., Orphanides G., Hasegawa J., Kim D.-K., Shima D.,
RA   Yamaguchi Y., Fukuda A., Hisatake K., Oh S., Reinberg D., Handa H.;
RT   "FACT relieves DSIF/NELF-mediated inhibition of transcriptional
RT   elongation and reveals functional differences between P-TEFb and
RT   TFIIH.";
RL   Mol. Cell 5:1067-1072(2000).
RN   [12]
RP   FUNCTION.
RX   PubMed=10757782; DOI=10.1128/MCB.20.9.2970-2983.2000;
RA   Ivanov D., Kwak Y.T., Guo J., Gaynor R.B.;
RT   "Domains in the SPT5 protein that modulate its transcriptional
RT   regulatory properties.";
RL   Mol. Cell. Biol. 20:2970-2983(2000).
RN   [13]
RP   FUNCTION, AND MUTAGENESIS OF ASP-167 AND THR-186.
RX   PubMed=11145967; DOI=10.1074/jbc.M010908200;
RA   Kim J.B., Sharp P.A.;
RT   "Positive transcription elongation factor B phosphorylates hSPT5 and
RT   RNA polymerase II carboxyl-terminal domain independently of cyclin-
RT   dependent kinase-activating kinase.";
RL   J. Biol. Chem. 276:12317-12323(2001).
RN   [14]
RP   FUNCTION.
RX   PubMed=11112772; DOI=10.1074/jbc.M006130200;
RA   Ping Y.-H., Rana T.M.;
RT   "DSIF and NELF interact with RNA polymerase II elongation complex and
RT   HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase
RT   II and DSIF during transcription elongation.";
RL   J. Biol. Chem. 276:12951-12958(2001).
RN   [15]
RP   FUNCTION.
RX   PubMed=11575923; DOI=10.1006/jmbi.2001.4991;
RA   Lavoie S.B., Albert A.L., Handa H., Vincent M., Bensaude O.;
RT   "The peptidyl-prolyl isomerase Pin1 interacts with hSpt5
RT   phosphorylated by Cdk9.";
RL   J. Mol. Biol. 312:675-685(2001).
RN   [16]
RP   INTERACTION WITH AFF4.
RX   MEDLINE=22060826; PubMed=12065898; DOI=10.1159/000059424;
RA   Estable M.C., Naghavi M.H., Kato H., Xiao H., Qin J., Vahlne A.,
RA   Roeder R.G.;
RT   "MCEF, the newest member of the AF4 family of transcription factors
RT   involved in leukemia, is a positive transcription elongation factor-b-
RT   associated protein.";
RL   J. Biomed. Sci. 9:234-245(2002).
RN   [17]
RP   FUNCTION.
RX   PubMed=11809800; DOI=10.1128/MCB.22.4.1079-1093.2002;
RA   Bourgeois C.F., Kim Y.K., Churcher M.J., West M.J., Karn J.;
RT   "Spt5 cooperates with human immunodeficiency virus type 1 Tat by
RT   preventing premature RNA release at terminator sequences.";
RL   Mol. Cell. Biol. 22:1079-1093(2002).
RN   [18]
RP   INTERACTION WITH SUPT5H.
RX   MEDLINE=22605552; PubMed=12718890; DOI=10.1016/S1097-2765(03)00101-1;
RA   Kwak Y.T., Guo J., Prajapati S., Park K.-J., Surabhi R.M., Miller B.,
RA   Gehrig P., Gaynor R.B.;
RT   "Methylation of SPT5 regulates its interaction with RNA polymerase II
RT   and transcriptional elongation properties.";
RL   Mol. Cell 11:1055-1066(2003).
RN   [19]
RP   FUNCTION.
RX   PubMed=15564463; DOI=10.1128/JVI.78.24.13522-13533.2004;
RA   Zhou M., Deng L., Lacoste V., Park H.U., Pumfery A., Kashanchi F.,
RA   Brady J.N., Kumar A.;
RT   "Coordination of transcription factor phosphorylation and histone
RT   methylation by the P-TEFb kinase during human immunodeficiency virus
RT   type 1 transcription.";
RL   J. Virol. 78:13522-13533(2004).
RN   [20]
RP   FUNCTION.
RX   PubMed=14701750; DOI=10.1128/MCB.24.2.787-795.2004;
RA   Fujinaga K., Irwin D., Huang Y., Taube R., Kurosu T., Peterlin B.M.;
RT   "Dynamics of human immunodeficiency virus transcription: P-TEFb
RT   phosphorylates RD and dissociates negative effectors from the
RT   transactivation response element.";
RL   Mol. Cell. Biol. 24:787-795(2004).
RN   [21]
RP   IDENTIFICATION IN THE 7SK SNRNP COMPLEX.
RX   PubMed=17643375; DOI=10.1016/j.molcel.2007.06.027;
RA   Jeronimo C., Forget D., Bouchard A., Li Q., Chua G., Poitras C.,
RA   Therien C., Bergeron D., Bourassa S., Greenblatt J., Chabot B.,
RA   Poirier G.G., Hughes T.R., Blanchette M., Price D.H., Coulombe B.;
RT   "Systematic analysis of the protein interaction network for the human
RT   transcription machinery reveals the identity of the 7SK capping
RT   enzyme.";
RL   Mol. Cell 27:262-274(2007).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-186, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-186; SER-347 AND
RP   SER-353, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-35;
RP   SER-52 AND SER-56 (ISOFORM 2), AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-185; THR-186; SER-347;
RP   THR-350 AND SER-353, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27;
RP   SER-35; SER-43; SER-52; THR-54; THR-55 AND SER-56; (ISOFORM 2), AND
RP   MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [26]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-59.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Member of the cyclin-dependent kinase pair (CDK9/cyclin-
CC       T) complex, also called positive transcription elongation factor b
CC       (P-TEFb), which facilitates the transition from abortive to
CC       production elongation by phosphorylating the CTD (C-terminal
CC       domain) of the large subunit of RNA polymerase II (RNAP II),
CC       SUPT5H and RDBP. The CDK9/cyclin-K complex has also a kinase
CC       activity toward CTD of RNAP II and can substitute for P-TEFb in
CC       vitro.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- CATALYTIC ACTIVITY: ATP + [DNA-directed RNA polymerase] = ADP +
CC       [DNA-directed RNA polymerase] phosphate.
CC   -!- SUBUNIT: Associates with CCNT1/cyclin-T1 to form P-TEFb. P-TEFb
CC       forms a complex with AFF4/AF5Q31. Also associates with
CC       CCNK/cyclin-K. Component of a complex which is at least composed
CC       of HTATSF1/Tat-SF1, P-TEFb complex, RNA pol II, SUPT5H, and
CC       NCL/nucleolin. Component of the 7SK snRNP complex at least
CC       composed of P-TEFb (composed of CDK9 and CCNT1/cyclin-T1), HEXIM1,
CC       HEXIM2, BCDIN3, SART3 proteins and 7SK and U6 snRNAs.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P50750-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P50750-2; Sequence=VSP_016288;
CC         Note=Phosphorylated on Ser-27, Ser-35, Ser-52, Thr-54, Thr55 and
CC         Ser-56;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAI39767.1; Type=Erroneous gene model prediction;
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cdk9/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L25676; AAA35668.1; -; mRNA.
DR   EMBL; X80230; CAA56516.1; -; mRNA.
DR   EMBL; AF255306; AAF72183.1; -; Genomic_DNA.
DR   EMBL; BT019903; AAV38706.1; -; mRNA.
DR   EMBL; AF517840; AAM54039.1; -; Genomic_DNA.
DR   EMBL; AL162586; CAI39767.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL162586; CAI39768.1; -; Genomic_DNA.
DR   EMBL; BC001968; AAH01968.1; -; mRNA.
DR   IPI; IPI00301923; -.
DR   IPI; IPI00552413; -.
DR   PIR; A55262; A55262.
DR   RefSeq; NP_001252.1; -.
DR   UniGene; Hs.150423; -.
DR   UniGene; Hs.706809; -.
DR   PDB; 1PF6; Model; -; A=1-372.
DR   PDB; 3BLH; X-ray; 2.48 A; A=2-330.
DR   PDB; 3BLQ; X-ray; 2.90 A; A=2-330.
DR   PDB; 3BLR; X-ray; 2.80 A; A=2-330.
DR   PDB; 3MI9; X-ray; 2.10 A; A=1-345.
DR   PDB; 3MIA; X-ray; 3.00 A; A=1-345.
DR   PDBsum; 1PF6; -.
DR   PDBsum; 3BLH; -.
DR   PDBsum; 3BLQ; -.
DR   PDBsum; 3BLR; -.
DR   PDBsum; 3MI9; -.
DR   PDBsum; 3MIA; -.
DR   ProteinModelPortal; P50750; -.
DR   DIP; DIP-29016N; -.
DR   IntAct; P50750; 40.
DR   MINT; MINT-1532814; -.
DR   STRING; P50750; -.
DR   PhosphoSite; P50750; -.
DR   PRIDE; P50750; -.
DR   Ensembl; ENST00000373264; ENSP00000362361; ENSG00000136807.
DR   Ensembl; ENST00000373265; ENSP00000362362; ENSG00000136807.
DR   GeneID; 1025; -.
DR   KEGG; hsa:1025; -.
DR   UCSC; uc004bse.2; human.
DR   CTD; 1025; -.
DR   GeneCards; GC09P130547; -.
DR   H-InvDB; HIX0008409; -.
DR   HGNC; HGNC:1780; CDK9.
DR   HPA; CAB004216; -.
DR   HPA; HPA006738; -.
DR   MIM; 603251; gene.
DR   PharmGKB; PA26316; -.
DR   eggNOG; prNOG12297; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; P50750; -.
DR   OMA; WRRKWRG; -.
DR   PhylomeDB; P50750; -.
DR   BRENDA; 2.7.11.22; 247.
DR   BRENDA; 2.7.11.23; 247.
DR   Reactome; REACT_1788; Transcription.
DR   Reactome; REACT_1892; Elongation arrest and recovery.
DR   Reactome; REACT_6185; HIV Infection.
DR   Reactome; REACT_71; Gene Expression.
DR   Reactome; REACT_769; Pausing and recovery of elongation.
DR   BindingDB; P50750; -.
DR   NextBio; 4305; -.
DR   ArrayExpress; P50750; -.
DR   Bgee; P50750; -.
DR   CleanEx; HS_CDK9; -.
DR   Genevestigator; P50750; -.
DR   GermOnline; ENSG00000136807; Homo sapiens.
DR   GO; GO:0008023; C:transcription elongation factor complex; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004693; F:cyclin-dependent protein kinase activity; TAS:ProtInc.
DR   GO; GO:0003677; F:DNA binding; IDA:MGI.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0008353; F:RNA polymerase II carboxy-terminal domain k...; IDA:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:MGI.
DR   GO; GO:0045449; P:regulation of transcription; IEA:UniProtKB-KW.
DR   GO; GO:0006368; P:RNA elongation from RNA polymerase II promoter; TAS:ProtInc.
DR   GO; GO:0006367; P:transcription initiation from RNA polymeras...; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transcription;
KW   Transcription regulation; Transferase.
FT   CHAIN         1    372       Cell division protein kinase 9.
FT                                /FTId=PRO_0000085800.
FT   DOMAIN       19    315       Protein kinase.
FT   NP_BIND      25     33       ATP (By similarity).
FT   ACT_SITE    149    149       Proton acceptor (By similarity).
FT   BINDING      48     48       ATP (By similarity).
FT   MOD_RES     185    185       Phosphotyrosine.
FT   MOD_RES     186    186       Phosphothreonine.
FT   MOD_RES     347    347       Phosphoserine.
FT   MOD_RES     350    350       Phosphothreonine.
FT   MOD_RES     353    353       Phosphoserine.
FT   VAR_SEQ       1      1       M -> MQRDAPPRAPAPAPRLPAPPIGAAASSGGGGGGGSG
FT                                GGGGGASAAPAPPGLSGTTSPRGPGGGRRAEEAGSAPRGRK
FT                                WPWRRKWRGRGGAWSAAAAGPGAGAAAAATGGGGGALEAAM
FT                                (in isoform 2).
FT                                /FTId=VSP_016288.
FT   VARIANT      59     59       F -> L (in dbSNP:rs55640715).
FT                                /FTId=VAR_041982.
FT   VARIANT     231    231       G -> A.
FT                                /FTId=VAR_013456.
FT   MUTAGEN     167    167       D->N: Abrogates kinase activity.
FT   MUTAGEN     186    186       T->A: Abrogates autophosphorylation; no
FT                                effect on kinase activity.
FT   CONFLICT    163    163       L -> P (in Ref. 4; AAV38706).
FT   HELIX        16     18
FT   STRAND       19     27
FT   STRAND       29     38
FT   TURN         39     41
FT   STRAND       44     49
FT   HELIX        61     72
FT   STRAND       81     86
FT   STRAND       99    104
FT   HELIX       110    114
FT   HELIX       123    142
FT   HELIX       152    154
FT   STRAND      155    157
FT   STRAND      163    165
FT   HELIX       192    194
FT   HELIX       197    200
FT   HELIX       209    224
FT   HELIX       234    245
FT   TURN        250    252
FT   HELIX       275    283
FT   HELIX       286    295
FT   TURN        300    302
FT   HELIX       306    311
FT   HELIX       313    315
FT   STRAND      316    319
SQ   SEQUENCE   372 AA;  42778 MW;  69E851CC6F7A0388 CRC64;
     MAKQYDSVEC PFCDEVSKYE KLAKIGQGTF GEVFKARHRK TGQKVALKKV LMENEKEGFP
     ITALREIKIL QLLKHENVVN LIEICRTKAS PYNRCKGSIY LVFDFCEHDL AGLLSNVLVK
     FTLSEIKRVM QMLLNGLYYI HRNKILHRDM KAANVLITRD GVLKLADFGL ARAFSLAKNS
     QPNRYTNRVV TLWYRPPELL LGERDYGPPI DLWGAGCIMA EMWTRSPIMQ GNTEQHQLAL
     ISQLCGSITP EVWPNVDNYE LYEKLELVKG QKRKVKDRLK AYVRDPYALD LIDKLLVLDP
     AQRIDSDDAL NHDFFWSDPM PSDLKGMLST HLTSMFEYLA PPRRKGSQIT QQSTNQSRNP
     ATTNQTEFER VF
//
